Cargando…
Circulating platelets as liquid biopsy sources for cancer detection
Nucleic acids and proteins are shed into the bloodstream by tumor cells and can be exploited as biomarkers for the detection of cancer. In addition, cancer detection biomarkers can also be nontumor‐derived, having their origin in other organs and cell types. Hence, liquid biopsies provide a source o...
Autores principales: | Antunes‐Ferreira, Mafalda, Koppers‐Lalic, Danijela, Würdinger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169446/ https://www.ncbi.nlm.nih.gov/pubmed/33219615 http://dx.doi.org/10.1002/1878-0261.12859 |
Ejemplares similares
-
Liquid Biopsy: Current Status and Future Perspectives
por: Baev, Vesselin, et al.
Publicado: (2023) -
In vitro cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood
por: Eslami-S, Zahra, et al.
Publicado: (2023) -
Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection
por: D’Ambrosi, Silvia, et al.
Publicado: (2023) -
isomiRs–Hidden Soldiers in the miRNA Regulatory Army, and How to Find Them?
por: Glogovitis, Ilias, et al.
Publicado: (2020) -
miRGalaxy: Galaxy-Based Framework for Interactive Analysis of microRNA and isomiR Sequencing Data
por: Glogovitis, Ilias, et al.
Publicado: (2021)